BDBM696647 (R) or (S)-N-(5-(3-hydroxy-3- methylpyrrolidin-1-yl)-2- (trifluoromethyl)pyridin-3-yl)- 6-(1-methyl-1H-pyrazol-4- yl)picolinamide::US20240308980, Ex-1.12::US20240308980, Ex-1.13

SMILES Cn1cc(cn1)-c1cccc(n1)C(=O)Nc1cc(cnc1C(F)(F)F)N1CCC(C)(O)C1

InChI Key InChIKey=BSAYWLXTZZOGJR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 696647   

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM696647(US20240308980, Ex-1.12 | (R) or (S)-N-(5-(3-hydrox...)
Affinity DataIC50: 1.60E+3nMAssay Description:Compound potency against LRRK2 kinase activity was determined using LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA) using a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM696647(US20240308980, Ex-1.12 | (R) or (S)-N-(5-(3-hydrox...)
Affinity DataIC50: 1.93E+3nMAssay Description:Compound potency against LRRK2 kinase activity was determined using LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA) using a...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
1/16/2025
Entry Details
US Patent